However, the persistent decrease of the serum ATX levels up to day 19 − 20 or later in the COVID-19 patients (Figure 1) suggested that some long-term mechanisms might be involved in the modulation of ATX in COVID-19. Here, ENPP2 is linked to COVID-19.